MedTrace Logo

Management Of Pain After Cesarean Trial

NCT03929640 · Status: TERMINATED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 49

Last updated 2024-09-04

Study results available
· View outcomes & findings →

Summary

This is a double blinded randomized controlled trial to test the efficacy of a combination of acetaminophen and ibuprofen administered to patients on schedule compared to ibuprofen alone on the patient's reported pain score on the second post-operative day after Cesarean delivery. The investigators will also record opiate consumption and pain scores throughout the hospitalization of participants, and will survey patients at one and two weeks after surgery regarding opiate consumption and quality of life.

Conditions

  • Pain, Postoperative
  • Opioid Use

Interventions

DRUG

Acetaminophen

Acetaminophen 650 mg tablet every 6 hours

DRUG

Placebo

Placebo oral tablet every 6 hours

DRUG

Ibuprofen

Ibuprofen 600 mg tablet every 6 hours

Sponsors & Collaborators

  • Milton S. Hershey Medical Center

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-08-05
Primary Completion
2020-03-14
Completion
2020-03-26
FDA Drug
Yes

Countries

  • United States

Study Locations

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03929640 on ClinicalTrials.gov